Identification of Potential Prognostic Biomarkers for Sorafenib Efficacy in Hepatocellular Carcinoma Cells by Proteomic Approaches
碩士 === 國立臺灣大學 === 生物化學暨分子生物學研究所 === 105 === Hepatocellular carcinoma, HCC, is the most common liver cancer in the world. Clinically, there are many biomarkers which can be used to diagnose HCC and predict prognosis. According to the Barcelona-clinic liver cancer staging (BCLC staging), sorafenib is...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2017
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/uxbqfs |